Is There a Therapeutic Window for Metabolism-Based Cancer Therapies?

Is There a Therapeutic Window for Metabolism-Based Cancer Therapies?

Bibliographic Details
Main Author:	Sarah-Maria Fendt
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-07-01
Series:	Frontiers in Endocrinology
Subjects:	metabolism cancer treatment metastasis formation endothelial cells immune cells
Online Access:	http://journal.frontiersin.org/article/10.3389/fendo.2017.00150/full

Similar Items

The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression
by: Oskar Ciesielski, et al.
Published: (2020-04-01)

Cellular and Exosomal Regulations of Sepsis-Induced Metabolic Alterations
by: Michael G. Appiah, et al.
Published: (2021-08-01)

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
by: Keisuke Watanabe, et al.
Published: (2018-10-01)

Endothelial cell-initiated extravasation of cancer cells visualized in zebrafish
by: Masamitsu Kanada, et al.
Published: (2014-12-01)

Intrinsic and Extrinsic Determinants of T Cell Metabolism in Health and Disease
by: Haydn Munford, et al.
Published: (2019-10-01)

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
by: Jing Chen, et al.
Published: (2018-06-01)

Interactions in the (Pre)metastatic Niche Support Metastasis Formation
by: Ginevra Doglioni, et al.
Published: (2019-04-01)

Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma
by: Adriana G. Quiroz-Reyes, et al.
Published: (2021-01-01)

Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells
by: Chen Guo, et al.
Published: (2019-06-01)

Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
by: Piotr Rhone, et al.
Published: (2019-11-01)

Vascular Normalization: A New Window Opened for Cancer Therapies
by: Ting Yang, et al.
Published: (2021-08-01)

The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
by: Atsushi Tanabe, et al.
Published: (2020-09-01)

Editorial: Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment
by: Yongsheng Li, et al.
Published: (2018-12-01)

Editorial: Targeting Metabolism in Cancer Immunotherapy
by: Jason Roszik, et al.
Published: (2018-09-01)

Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment
Published: (2019)

Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
by: Jae Hyung Park, et al.
Published: (2020-10-01)

Targeting Receptor Tyrosine Kinase on Lymphatic Endothelial Cells for the Therapy of Colon Cancer Lymph Node Metastasis
by: Robert B. Rebhun, et al.
Published: (2006-09-01)

Endothelial-to-Mesenchymal Transition in Cancer
by: Nicolas Clere, et al.
Published: (2020-08-01)

Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities
by: Alice Turdo, et al.
Published: (2020-05-01)

Metabolic vulnerabilities of metastasizing cancer cells
by: Sarah-Maria Fendt
Published: (2019-07-01)

Endothelial cells promote metastasis of prostate cancer by enhancing autophagy
by: Ruizhe Zhao, et al.
Published: (2018-09-01)

Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs
by: Shuai Huang, et al.
Published: (2015-08-01)

Cancer Stem Cell Metabolism and Potential Therapeutic Targets
by: Vusala Snyder, et al.
Published: (2018-06-01)

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy
by: Zhongping Yin, et al.
Published: (2019-09-01)

The contributions of cancer cell metabolism to metastasis
by: Gloria Pascual, et al.
Published: (2018-08-01)

Targeting the Metabolic Adaptation of Metastatic Cancer
by: Josep Tarragó-Celada, et al.
Published: (2021-04-01)

Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
by: Xingyue Zong, et al.
Published: (2019-07-01)

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.
by: Shona A Hendry, et al.
Published: (2016-12-01)

Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
by: Petra Jagust, et al.
Published: (2019-03-01)

Preclinical validation of a novel metastasis‐inhibiting Tie1 function‐blocking antibody
by: Mahak Singhal, et al.
Published: (2020-06-01)

Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy
by: Zhang H, et al.
Published: (2021-06-01)

Ping-Pong—Tumor and Host in Pancreatic Cancer Progression
by: Wei Mu, et al.
Published: (2019-12-01)

Tumor Endothelial Heterogeneity in Cancer Progression
by: Nako Maishi, et al.
Published: (2019-10-01)

The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer
by: Yina Yu, et al.
Published: (2020-06-01)

Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment
by: Zhou Jiang, et al.
Published: (2020-07-01)

Properties and feasibility of using cancer stem cells in clinical cancer treatment
by: Xiao-Mei Gao, et al.
Published: (2016-12-01)

Fatty acids – from energy substrates to key regulators of cell survival, proliferation and effector function
by: Danilo Cucchi, et al.
Published: (2019-12-01)

Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression
by: Antonio Sica, et al.
Published: (2019-07-01)

Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
by: Matthias Läsche, et al.
Published: (2020-03-01)

miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression
by: Miao Li, et al.
Published: (2020-09-01)